Opioid-related Data in New York State
In response to the growing opioid public health crisis and recommendations to improve the timeliness of reporting opioid-related data, the New York State Department of Health (NYSDOH) Opioid Prevention Program provides opioid-related data to support statewide prevention efforts. These efforts include improving timely opioid overdose reporting to key stakeholders. This information is a valuable tool for planning and can help identify where communities are struggling, help tailor interventions, and show improvements.
This website is designed to provide comprehensive and useful data and information regarding opioid use and misuse. New resources will be added often. Please check back frequently.
New York State Opioid Data Dashboards
New York State Opioid Annual Reports
New York State Opioid Data to Action Reports
The Data to Action Reports are short communications on important topics that provide specific opioid-related data to mobilize public health action. Reports include key messages, quick facts describing the topics, figures illustrating relevant data, language describing recommendations, evidence-based approaches, and suggested actions and resources.
- Opioid Prescribing in New York State
- Xylazine Awareness in New York State, 2021
- New York State (excluding New York City) Overdose Data To Action (OD2A) syndromic surveillance opioid overdose 2021 annual data brief
- Pre-hospital Care Reports – Improving Data Reporting and Data Quality Supports Public Health Response in New York State, 2015-2021
- Continuous buprenorphine prescriptions for 6 months or more for the treatment of opioid use disorder in New York State, 2017-2021
- Overdose Deaths Involving Methamphetamine With and Without Fentanyl in New York State, Outside of New York City, 2016-2020
- Buprenorphine for the treatment of opioid use disorders (OUD) in New York State, 2016-2019
- Overdose Deaths Involving Cocaine With and Without Opioids in New York State, 2010-2019
- Opioid-related Mortality and Public Perceptions in New York State
- Fentanyl-related deaths in New York State outside of New York City, 2015-2017
Technical Assistance for Opioid Data Indicators
This section contains resources to help users navigate the data website, understand the indicators, and interpret the data. Additional resources will be added periodically.
Other publications
- Basic Needs among People Who Use Opioids in New York City during the COVID-19 Pandemic
- Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2020
- Drug overdose deaths in the United States, 1999–2020. NCHS Data Brief, no 428. Hyattsville, MD: National Center for Health Statistics. 2021
- The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
- Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020
- Notes from the Field: Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose — Four States, October 6, 2020–March 9, 2021
- Prevalence of and characteristics associated with single- and polydrug-involved U.S. Emergency Department Visits in 2018
- Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction
- New York State's Heroin and Opioid Task Force Report, June 9, 2016
- Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015
- Incidence of Neonatal Abstinence Syndrome — 28 States, 1999–2013
- A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders - Practice and Policy Considerations for Child Welfare, Collaborating Medical, and Service Providers
- Opioid Prescriptions Among Women of Reproductive Age Enrolled in Medicaid – New York, 2008-2013
- Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015
- Controlled Substance Prescribing Patterns - Prescription Behavior Surveillance System, Eight States, 2013
- CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016
- Reducing the Risks of Relief - The CDC Opioid-Prescribing Guideline
- Recommendations and Lessons Learned for Improved Reporting of Drug Overdose Deaths on Death Certificates - Council of State and Territorial Epidemiologists
- Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
- Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014
- Overdose Prevention for Prisoners in New York: a Novel Program and Collaboration
- National Association of Medical Examiners Position Paper: Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid Drugs
- The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths
- Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2010-2014
- Epi Data Brief: Unintentional Drug Poisoning (Overdose) Deaths Involving Heroin and/or Fentanyl in New York City, 2000-2015
- Epi Data Tables: Unintentional Drug Poisoning (Overdose) Deaths Involving Heroin and/or Fentanyl in New York City, 2012-2015
- Public Health Detailing-A Successful Strategy to Promote Judicious Opioid Analgesic Prescribing
- Epi Data Brief: Patterns of Opioid Analgesic Prescriptions for New York City Residents
- Epi Data Brief: Opioid Analgesics in New York City: Prescriber Practices
- Decrease in Rate of Opioid Analgesic Overdose Deaths - Staten Island, New York City, 2011-2013
